A detailed history of Bank Of Montreal transactions in Glaukos Corp stock. As of the latest transaction made, Bank Of Montreal holds 9,134 shares of GKOS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,134
Previous 8,880 2.86%
Holding current value
$1.29 Million
Previous $1.05 Million 13.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $28,859 - $34,389
254 Added 2.86%
9,134 $1.19 Million
Q2 2024

Aug 14, 2024

SELL
$89.48 - $118.35 $420,645 - $556,363
-4,701 Reduced 34.61%
8,880 $1.05 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $389,105 - $490,608
5,093 Added 60.0%
13,581 $1.28 Million
Q4 2023

Feb 08, 2024

BUY
$59.53 - $85.11 $11,846 - $16,936
199 Added 2.4%
8,488 $674,000
Q3 2023

Nov 01, 2023

BUY
$69.23 - $79.09 $2,976 - $3,400
43 Added 0.52%
8,289 $623,000
Q2 2023

Aug 02, 2023

SELL
$45.44 - $71.21 $795,518 - $1.25 Million
-17,507 Reduced 67.98%
8,246 $587,000
Q1 2023

Jun 13, 2024

BUY
$43.88 - $52.48 $591,677 - $707,640
13,484 Added 99.29%
27,065 $1.36 Million
Q4 2022

Feb 01, 2023

BUY
$40.82 - $57.75 $670,795 - $949,005
16,433 Added 176.32%
25,753 $1.12 Million
Q3 2022

Nov 10, 2022

SELL
$46.84 - $58.49 $5,948 - $7,428
-127 Reduced 1.34%
9,320 $531,000
Q2 2022

Aug 11, 2022

SELL
$34.86 - $63.77 $368,958 - $674,941
-10,584 Reduced 52.84%
9,447 $451,000
Q1 2022

May 12, 2022

BUY
$44.33 - $57.82 $110,160 - $143,682
2,485 Added 14.16%
20,031 $1.16 Million
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $96,728 - $136,889
-2,402 Reduced 12.04%
17,546 $808,000
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $6,545 - $11,623
-138 Reduced 0.69%
19,948 $987,000
Q2 2021

Aug 12, 2021

BUY
$73.06 - $97.7 $1.47 Million - $1.96 Million
20,086 New
20,086 $1.72 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.7B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.